From traditional to targeted: the changing trajectory of therapies in dermatomyositis.

PURPOSE OF REVIEW: New breakthroughs in our understanding of dermatomyositis (DM) have spawned the recent development of novel agents that specifically target key drivers in DM immunopathogenesis. This review aims to provide a comprehensive overview of new and forthcoming therapies for DM and to highlight their mechanisms of action, best evidence to date, and potential impact on disease management. RECENT FINDINGS: Strategies that either counteract dysregulated interferon signaling [via the inhibition of interferon ß, the type I interferon receptor subunit 1 (IFNAR1), or janus kinase (JAK)-signal transducer and activator of transcription (STAT) transduction] or induce durable autoreactive B cell depletion through chimeric antigen receptor (CAR) T-cell therapy appear to hold the most promise for sustained remission in DM. SUMMARY: The trajectory of DM treatments is rapidly evolving, fueled by the unparalleled insights provided by multiomic studies and big data analysis pipelines. Targeted therapies that maximize both efficacy and safety have the potential to complement or replace traditional immunosuppressives and revolutionize the approach to the management of DM.

Size Dependence of Liquid-Liquid Phase Separation by in Situ Study of Flowing Submicron Aerosol Particles.

Liquid-liquid phase separation (LLPS) of atmospheric particles impacts a range of atmospheric processes. Driven by thermodynamics, LLPS occurs in mixed organic-inorganic particles when high inorganic salt concentrations exclude organic compounds, which develop into a separate phase. The effect of particle size on the thermodynamic and kinetic drivers of LLPS, however, remains incompletely understood. Here, the size dependence was studied for the separation relative humidity (SRH) of LLPS. Submicron organic-inorganic aerosol particles of ammonium sulfate mixed with 1,2,6-hexanetriol and polyethylene glycol (PEG) were studied. In a flow configuration, upstream size selection was coupled to a downstream fluorescence aerosol flow tube (F-AFT) at 293 ± 1 K. For both mixed particle types, the SRH values for submicron particle diameters of 260-410 nm agreed with previous measurements reported in the literature for supermicron particles. For smaller particles, the SRH values decreased by approximately 5% RH for diameters of 130-260 nm for PEG-sulfate particles and of 70-190 nm for hexanetriol-sulfate particles. From these observations, the nucleation rate in the hexanetriol-sulfate system was constrained, implying an activation barrier to nucleation of +1.4 to +2.0 × 10-19 J at 70% RH and 293 K. Quantifying the activation barrier is an approach for predicting size-dependent LLPS in the atmosphere.